Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | BCL2 | P10415 | 3/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 3/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | PTPRC | P08575 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24688941 | 0.83 | ALDH1A1 (0.43) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL30833582 | 0.83 | MEN1 (0.55) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL30501016 | 0.83 | MEN1 (0.55) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL357510 | 0.83 | MEN1 (0.55) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL19695980 | 0.82 | TDP1 (0.48) | SMN1; SMN2ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL24183984 | 0.82 | TDP1 (0.48) | SMN1; SMN2ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL2381810 | 0.81 | ALDH1A1 (0.46) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL24688939 | 0.80 | ELANE (0.40) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL24688942 | 0.79 | POLB (0.48) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL17054434 | 0.78 | PGR (0.48) | SMN1; SMN2NPC1RAB9AALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220140249-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2022-05-05 | — | — | US | disclosed |
| WO-2014104666-A1 | INK COMPOSITION FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT USING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014104666-A1 | INK COMPOSITION FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT USING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-8395144-B2 | Anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2013-03-12 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-10 | — | — | US | disclosed |
| WO-2009139580-A2 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 (KR) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009139580-A2 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 (KR) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057182-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | TRPA1, AHR, ORAI2 | SMN1; SMN2 4270/4885NPC1 4184/4885RAB9A 2359/4885 |
| US-20220140249-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CDYL, MRPL38, CDYL2 | SMN1; SMN2 1747/4885NPC1 4043/4885RAB9A 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.